miRNA-21 and miRNA-27b Expression in Saliva of Patients with Oral Lichen Planus: A Systematic Review
- PMID: 40565287
- PMCID: PMC12193188
- DOI: 10.3390/ijms26125824
miRNA-21 and miRNA-27b Expression in Saliva of Patients with Oral Lichen Planus: A Systematic Review
Abstract
Oral lichen planus (OLP) is a chronic inflammatory disorder of the oral mucosa with a recognized risk of malignant transformation. MicroRNAs, particularly miRNA-21 and miRNA-27b, have been implicated in the pathogenesis and progression of various diseases, including OLP. Their altered expression in saliva may provide diagnostic and prognostic insights for this condition. This systematic review examines the expression profiles of miRNA-21 and miRNA-27b in the saliva of OLP patients to assess their potential as biomarkers. The review was conducted in accordance with PRISMA guidelines and was registered in the PROSPERO database. A comprehensive search was conducted in PubMed, Embase, and Scopus using specific keywords. Retrieved titles and abstracts were screened based on predefined eligibility criteria, and relevant studies were analyzed. The initial search identified 71 studies. After screening, 17 abstracts were selected for full-text review. Following evaluation, 11 studies were excluded, resulting in 6 studies being included. Findings indicate a consistent upregulation of miRNA-21 and a downregulation of miRNA-27b in OLP saliva samples. These alterations suggest a potential role in disease pathogenesis and risk assessment. The dysregulation of miRNA-21 and miRNA-27b in OLP underscores their potential as salivary biomarkers for diagnosis and disease monitoring. Moreover, the non-invasive nature of salivary miRNAs offers promising clinical applications, enhancing early detection and personalized management strategies for OLP.
Keywords: OLP; miRNA; microRNA; oral lichen planus.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by In silico Analysis of Differential Gene Expression.Curr Pharm Des. 2024;30(4):310-322. doi: 10.2174/0113816128276149240108163407. Curr Pharm Des. 2024. PMID: 38310566
-
"Exploring the Link Between Oral Lichen Planus and Xerostomia: A Systematic Literature Review".Immun Inflamm Dis. 2024 Dec;12(12):e70101. doi: 10.1002/iid3.70101. Immun Inflamm Dis. 2024. PMID: 39698938 Free PMC article.
-
Variations in salivary microbiota and metabolic phenotype related to oral lichen planus with psychiatric symptoms.BMC Oral Health. 2025 Jul 2;25(1):993. doi: 10.1186/s12903-025-06439-8. BMC Oral Health. 2025. PMID: 40604917 Free PMC article.
-
Cytokines, cortisol, and nitric oxide as salivary biomarkers in oral lichen planus: a systematic review.Braz Oral Res. 2018 Aug 13;32:e82. doi: 10.1590/1807-3107bor-2018.vol32.0082. Braz Oral Res. 2018. PMID: 30110084
-
A Systematic Review of Interleukin-17 in Oral Lichen Planus: From Etiopathogenesis to Treatment.Clin Med Res. 2023 Dec;21(4):201-215. doi: 10.3121/cmr.2023.1822. Clin Med Res. 2023. PMID: 38296640 Free PMC article.
References
-
- Guan G., Mei L., Polonowita A., Hussaini H., Seo B., Rich A.M. Malignant Transformation in Oral Lichen Planus and Lichenoid Lesions: A 14-Year Longitudinal Retrospective Cohort Study of 829 Patients in New Zealand. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2020;130:411–418. doi: 10.1016/j.oooo.2020.07.002. - DOI - PubMed
-
- Aghbari S.M.H., Abushouk A.I., Attia A., Elmaraezy A., Menshawy A., Ahmed M.S., Elsaadany B.A., Ahmed E.M. Malignant Transformation of Oral Lichen Planus and Oral Lichenoid Lesions: A Meta-Analysis of 20095 Patient Data. Oral Oncol. 2017;68:92–102. doi: 10.1016/j.oraloncology.2017.03.012. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources